{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:52:46Z","timestamp":1790959966793,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.eplepsyres.2017.09.012","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T17:46:17Z","timestamp":1505843177000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis"],"prefix":"10.1016","volume":"137","author":[{"given":"Michael S.","family":"Pohlen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie S.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yebeh.2016.03.011","article-title":"Lacosamide in patients with temporal lobe epilepsy: an observational multicentric open-label study","volume":"58","author":"Borz\u00ec","year":"2016","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/0004-282X20140199","article-title":"Patterns of seizure control in patients with mesial temporal lobe epilepsy with and without hippocampus sclerosis","volume":"73","author":"Coan","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0015","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1212\/WNL.57.12.2259","article-title":"Response to first drug trial predicts outcome in childhood temporal lobe epilepsy","volume":"57","author":"Dlugos","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0020","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/ene.13005","article-title":"Long-term prognosis of epilepsy, prognostic patterns and drug resistance: a population-based study","volume":"23","author":"Giussani","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2012.09.010","article-title":"Clinical phenotypes within non-surgical patients with mesial temporal lobe epilepsy caused by hippocampal sclerosis based on response to antiepileptic drugs","volume":"22","author":"Gomez-Iba\u00f1ez","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0030","first-page":"e1","article-title":"The health insurance gap after implementation of the affordable care act in Texas","volume":"113","author":"Gong","year":"2017","journal-title":"Tex. Med."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1528-1157.1999.tb00706.x","article-title":"The prognosis for control of seizures with medications in patients with MRI evidence for mesial temporal sclerosis","volume":"40","author":"Kim","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/seiz.2001.0614","article-title":"Treatment outcome in patients with mesial temporal sclerosis","volume":"11","author":"Kumlien","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0045","doi-asserted-by":"crossref","first-page":"e0159464","DOI":"10.1371\/journal.pone.0159464","article-title":"Very long-term outcome of non-surgically treated patients with temporal lobe epilepsy with hippocampal sclerosis: a retrospective study","volume":"11","author":"Kurita","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clineuro.2016.03.018","article-title":"Seizure outcome following medical treatment of mesial temporal lobe epilepsy: clinical phenotypes and prognostic factors","volume":"144","author":"Kuzmanovski","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0060","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl. 4","key":"10.1016\/j.eplepsyres.2017.09.012_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2012.03610.x","article-title":"Hippocampal sclerosis-origins and imaging","volume":"53","author":"Malmgren","year":"2012","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2017.09.012_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1528-1167.2008.01969.x","article-title":"Prognostic factors in patients with mesial temporal lobe epilepsy","volume":"50","author":"Pittau","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.seizure.2014.03.003","article-title":"Factors predicting the outcome following medical treatment of mesial temporal epilepsy with hippocampal sclerosis","volume":"23","author":"S\u00e0nchez","year":"2014","journal-title":"Seizure\u2014Eur. J. Epilepsy"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0080","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archneur.59.6.1042-a","article-title":"HIppocampal sclerosis and other hippocampal abnormalities in the early identification of candidates for epilepsy surgery","volume":"59","author":"Semah","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1528-1157.2001.29000.x","article-title":"Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?","volume":"42","author":"Stephen","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.eplepsyres.2009.03.001","article-title":"Prognosis of patients with mesial temporal lobe epilepsy due to hippocampal sclerosis","volume":"85","author":"Varoglu","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJM200108023450501","article-title":"A randomized, controlled trial of surgery for temporal-lobe epilepsy","volume":"345","author":"Wiebe","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2017.09.012_bib0100","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0013-9580.2004.09004.x","article-title":"ILAE commission report. Mesial temporal lobe epilepsy with hippocampal sclerosis","volume":"45","author":"Wieser","year":"2004","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117302759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117302759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:37:41Z","timestamp":1760276261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121117302759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":20,"alternative-id":["S0920121117302759"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.09.012","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}